175 related articles for article (PubMed ID: 22886469)
1. Primary Sjögren's syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia.
Ismail F; Mahmoud A; Abdelhaleem H; Mamdoh A; Geneidy M; Kamal E
Rheumatol Int; 2013 Apr; 33(4):1021-5. PubMed ID: 22886469
[TBL] [Abstract][Full Text] [Related]
2. CD4+ T-lymphocytopenia--a frequent finding in anti-SSA antibody seropositive patients with primary Sjögren's syndrome.
Mandl T; Bredberg A; Jacobsson LT; Manthorpe R; Henriksson G
J Rheumatol; 2004 Apr; 31(4):726-8. PubMed ID: 15088298
[TBL] [Abstract][Full Text] [Related]
3. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
Front Immunol; 2021; 12():705079. PubMed ID: 34484201
[TBL] [Abstract][Full Text] [Related]
4. Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.
Ciccia F; Guggino G; Rizzo A; Bombardieri M; Raimondo S; Carubbi F; Cannizzaro A; Sireci G; Dieli F; Campisi G; Giacomelli R; Cipriani P; De Leo G; Alessandro R; Triolo G
Clin Exp Immunol; 2015 Aug; 181(2):219-29. PubMed ID: 25880879
[TBL] [Abstract][Full Text] [Related]
5. CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjögren's syndrome.
Kirtava Z; Blomberg J; Bredberg A; Henriksson G; Jacobsson L; Manthorpe R
Clin Exp Rheumatol; 1995; 13(5):609-16. PubMed ID: 8575139
[TBL] [Abstract][Full Text] [Related]
6. Aberrant IL-35 levels in patients with primary Sjogren's syndrome.
Guo J; Gu M; Zhang W; Liu Y; Qian C; Deng A
Scand J Immunol; 2018 Nov; 88(5):e12718. PubMed ID: 30589451
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic CD4+ T-lymphocytopenia in a non-Hodgkin's lymphoma patient.
Hanamura I; Wakita A; Harada S; Tsuboi K; Komatsu H; Banno S; Iwaki O; Takeuchi G; Nitta M; Ueda R
Intern Med; 1997 Sep; 36(9):643-6. PubMed ID: 9313110
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4
Hong X; Meng S; Tang D; Wang T; Ding L; Yu H; Li H; Liu D; Dai Y; Yang M
Front Immunol; 2020; 11():594658. PubMed ID: 33603736
[TBL] [Abstract][Full Text] [Related]
9. Serum CXCL13 levels are associated with lymphoma risk and lymphoma occurrence in primary Sjögren's syndrome.
Traianos EY; Locke J; Lendrem D; Bowman S; Hargreaves B; Macrae V; ; Tarn JR; Ng WF
Rheumatol Int; 2020 Apr; 40(4):541-548. PubMed ID: 32047959
[TBL] [Abstract][Full Text] [Related]
10. Increased percentage of CD8+CD28- T cells correlates with clinical activity in primary Sjögren's syndrome.
Smoleńska Z; Pawłowska J; Zdrojewski Z; Daca A; Bryl E
Cell Immunol; 2012; 278(1-2):143-51. PubMed ID: 22975109
[TBL] [Abstract][Full Text] [Related]
11. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
[TBL] [Abstract][Full Text] [Related]
12. Increased frequency of CCR7
Wu C; Yang P; Liu H; Xiao W; Zhao L
Cytokine; 2018 Oct; 110():9-17. PubMed ID: 29684636
[TBL] [Abstract][Full Text] [Related]
13. CCL5 Release by CCR9+ CD8 T Cells: A Potential Contributor to Immunopathology of Primary Sjögren's Syndrome.
Hinrichs AC; Blokland SLM; Kruize AA; Lafeber FPJ; Leavis HL; van Roon JAG
Front Immunol; 2022; 13():887972. PubMed ID: 35720379
[TBL] [Abstract][Full Text] [Related]
14. CD4 cytopenia and occasional expansion of CD4+CD8+lymphocytes in Sjögren's syndrome.
Ferraccioli GF; Tonutti E; Casatta L; Pegoraro I; De Vita S; Sala P; Ravaioli T; Bartoli E
Clin Exp Rheumatol; 1996; 14(2):125-30. PubMed ID: 8737717
[TBL] [Abstract][Full Text] [Related]
15. Alteration of CD226/TIGIT immune checkpoint on T cells in the pathogenesis of primary Sjögren's syndrome.
Deng C; Chen Y; Li W; Peng L; Luo X; Peng Y; Zhao L; Wu Q; Zhang W; Zhang X; Fei Y
J Autoimmun; 2020 Sep; 113():102485. PubMed ID: 32466852
[TBL] [Abstract][Full Text] [Related]
16. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X
J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046
[TBL] [Abstract][Full Text] [Related]
17. CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity.
Alessandri C; Ciccia F; Priori R; Astorri E; Guggino G; Alessandro R; Rizzo A; Conti F; Minniti A; Barbati C; Vomero M; Pendolino M; Finucci A; Ortona E; Colasanti T; Pierdominici M; Malorni W; Triolo G; Valesini G
Arthritis Res Ther; 2017 Jul; 19(1):178. PubMed ID: 28743286
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study.
Quartuccio L; Isola M; Baldini C; Priori R; Bartoloni Bocci E; Carubbi F; Maset M; Gregoraci G; Della Mea V; Salvin S; De Marchi G; Luciano N; Colafrancesco S; Alunno A; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
J Autoimmun; 2014 Jun; 51():75-80. PubMed ID: 24231556
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjögren's syndrome.
Ichikawa Y; Arimori K; Yoshida M; Horiki T; Hoshina Y; Morita K; Uchiyama M; Shimizu H; Moriuchi J; Takaya M
Clin Exp Rheumatol; 1995; 13(3):307-13. PubMed ID: 7554556
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic role of CXCL13 biomarker in primary Sjogren's syndrome patients with parotid non-Hodgkin's lymphoma complication.
Badarinza M; Serban O; Maghear L; Pelea MA; Rosca RI; Fodor D; Stancu B
Med Clin (Barc); 2023 Jun; 160(11):484-488. PubMed ID: 37005121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
